Article info
PDFConcise report
An eight year prospective study of outcome prediction by antiperinuclear factor and antikeratin antibodies at onset of rheumatoid arthritis
- Correspondence to:
Professor O Meyer, Hôpital Bichat Claude Bernard, 46 rue Henri Huchard, 75018 Paris, France;
olivier.meyer{at}bch.ap-hop-paris.fr
Citation
An eight year prospective study of outcome prediction by antiperinuclear factor and antikeratin antibodies at onset of rheumatoid arthritis
Publication history
- Accepted March 4, 2002
- First published August 1, 2002.
Online issue publication
October 25, 2017
Copyright information
Copyright 2002 by Annals of the Rheumatic Diseases